FDA Inspection 1013962 — Flexion Therapeutics, Inc.
The FDA completed an inspection of Flexion Therapeutics, Inc. on June 13, 2017 in Burlington, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Devices.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- June 13, 2017
- Fiscal Year
- 2017
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Burlington, MA (United States)